- Meeting abstract
- Published:
Low dose pentoxifylline (PTX) reduces mortality in an animal model of acute hepatic and multi-organ failure
Critical Care volume 5, Article number: P081 (2001)
Introduction
Pentoxifylline inhibits, release of TNF-α, platelet aggregation and adherence of leukocytes to endothelium. Previous studies report increased mortality following its use.
Methods
AHF is induced by two intraperitoneal (i.p.) injections (500 mg/kg 8 hours apart) of TAA. Four groups were studied (n = 5). Group 1 received TAA only. Groups 2, 3, & 4 followed the protocol for Group 1, however, Groups 2 and 3 were pre-treated for 5 days with once daily high dose PTX (300 mg/kg i.p.) and low dose PTX (25 mg/kg i.p.), respectively. Whereas, Group 4, commenced PTX (25 mg/kg i.p.) post-TAA for 5 days. Mortality was determined at 96 hours in separate groups (n = 5).
Results
See Table.
Conclusion
Pre-treatment with low dose PTX reduces hepatic injury, multi-organ failure and mortality.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rahman, T., Hodgson, H. Low dose pentoxifylline (PTX) reduces mortality in an animal model of acute hepatic and multi-organ failure. Crit Care 5 (Suppl 1), P081 (2001). https://doi.org/10.1186/cc1148
Received:
Published:
DOI: https://doi.org/10.1186/cc1148